The condition that includes obesity, diabetes, high cholesterol and hypertension is called Metabolic Syndrome. The treatment of Metabolic Syndrome by surgical methods is called Metabolic Surgery. Metabolic Syndrome includes conditions of obesity, type 2 diabetes, hypertension and cholesterol metabolism malfunction.
The surgical treatment of type II diabetes was raised for the first time in the study where it is mentioned that the impulses (incretins] occurring in the small intestine upon closure of the duodenum and the proximal jejunum for food entrance plays an important role for the regulation of blood sugar. Put simply, metabolic surgery application either takes the food to the ileum or the ileum to the food. The ileum meets the food in earlier stages of the digestion with the Ileal Interposition operations. It is emphasized that the documented effects of the surgeries occur due to the small intestine sourced hormones (incretins).
Whilst not all mechanisms providing the high resolution possibility are explained in full, Metabolic Surgery applications provide an efficient and longtermed resolution in the treatment of the Metabolic Syndrome and its component. Perhaps most importantly these applications can achieve a resolution at ratios varying between 25% and 98% in type II diabetes. The possibly most important point to be emphasized in the light of this knowledge is that metabolic surgery applications change the course of type II diabetes by making changes to intestinally sourced hormonal transmission mechanisms rather than to a mechanical new passage or a non-specific malabsorption.